Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Restructuring Costs (2018 - 2021)

Historic Restructuring Costs for iBio (IBIO) over the last 4 years, with Q4 2021 value amounting to $61000.0.

  • iBio's Restructuring Costs fell 6553.67% to $61000.0 in Q4 2021 from the same period last year, while for Jun 2022 it was $250000.0, marking a year-over-year decrease of 6639.78%. This contributed to the annual value of $250000.0 for FY2022, which is 6639.78% down from last year.
  • Per iBio's latest filing, its Restructuring Costs stood at $61000.0 for Q4 2021, which was down 6553.67% from $189000.0 recorded in Q3 2021.
  • iBio's 5-year Restructuring Costs high stood at $304000.0 for Q4 2018, and its period low was $61000.0 during Q4 2021.
  • Over the past 4 years, iBio's median Restructuring Costs value was $187000.0 (recorded in 2020), while the average stood at $197214.3.
  • Its Restructuring Costs has fluctuated over the past 5 years, first skyrocketed by 818.71% in 2020, then tumbled by 6553.67% in 2021.
  • Quarter analysis of 4 years shows iBio's Restructuring Costs stood at $304000.0 in 2018, then plummeted by 45.72% to $165000.0 in 2019, then grew by 7.27% to $177000.0 in 2020, then tumbled by 65.54% to $61000.0 in 2021.
  • Its last three reported values are $61000.0 in Q4 2021, $189000.0 for Q3 2021, and $193000.0 during Q2 2021.